Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$28,137,399
+$17,682,059 QoQ
Shares Held
8,016,353
+109.3% QoQ
Ownership
1.80%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Derivatives in IOVA
reported options exposure · as of Jun 30, 2024CallValue
$182,856
CallShares
22,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. IOVA ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in IOVA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,137,399 | 8,016,353 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,455,340 | 3,829,795 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $165,373 | 76,209 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $95,410 | 55,471 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $130,789 | 39,276 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $228,008 | 30,812 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $636,153 | 67,748 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,259,756 | 655,830 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $182,856 | 22,800 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $1,028,508 | 69,400 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $1,247,844 | 84,200 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $34,859,100 | 2,352,166 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,749,039 | 215,134 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $171,817 | 37,762 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,045,641 | 858,756 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,419,300 | 2,359,951 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,977,046 | 4,221,760 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,820,207 | 2,695,220 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,935,941 | 2,077,531 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,075,039 | 124,627 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $582,245 | 30,500 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $1,375,186 | 72,037 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $752,130 | 30,500 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $234,615 | 9,514 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $665,747 | 25,586 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $793,610 | 30,500 | Put | Defined | 2021-08-16 | |
| 2021-03-31 | $7,527,766 | 237,769 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,975,437 | 128,781 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,527,158 | 46,390 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $549,000 | 20,000 | Call | Defined | 2020-08-14 | |
| 2020-03-31 | $799,847 | 26,715 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $1,197,600 | 40,000 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||